NCT03203291

Brief Summary

OBJECTIVES: The purpose of this study is to evaluate the overall feasibility in terms of safety, treatment tolerance and adherence as well as preliminarily address how effective this treatment model using the TPAD and overground training would be to reduce load asymmetry on the treadmill and promote increased stance symmetry on the paretic limb during overground gait.PARTICIPANTS: A total of 12 individuals in the chronic (\>6 months) stages post stroke will be recruited from a voluntary stroke research database for participation. DESIGN: A non-randomized pilot study of feasibility will be used to establish the feasibility and preliminary efficacy of using the TPAD in combination with overground training to reduce load force asymmetry in this population. METHODS: Participants will undergo a series of three assessments within a one-week time frame prior to initiating intervention. Intervention using the TPAD and overground training will occur during week 2 over 5 consecutive visits (Mon-Fri). Participants will also complete short walks before and after the intervention with an instrumented system that records individual walking characteristics. Participants will return one-week after completing the intervention for a final test of walking and balance. Each study visit will be approximately 1-1.5 hours in duration, and total participation should be completed within three weeks. EXPECTED OUTCOMES: We anticipate this training paradigm will prove feasible and effective in reducing both load and stance asymmetry in a population of individuals with chronic stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

October 28, 2019

Completed
Last Updated

June 9, 2020

Status Verified

June 1, 2020

Enrollment Period

1.1 years

First QC Date

June 24, 2017

Results QC Date

July 16, 2018

Last Update Submit

June 2, 2020

Conditions

Keywords

strokerobotic traininggait

Outcome Measures

Primary Outcomes (2)

  • Force Symmetry Ratio During Gait

    0-1 symmetry ratio comparing the impulse force of the affected limb versus the unaffected limb during gait. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.

    Baseline through day 5

  • Stance Time Symmetry Ratio

    0-1 symmetry ratio of the percentage of time spent in the stance phase of a gait cycle. If the unaffected limb performs equivalent to the affected limb, the ratio will have a value of 1. The greater the disparity the closer the ratio is to 0. Stance time symmetry = Time in stance phase of gait cycle of Affected/Unaffected limb.

    Baseline through week 3

Secondary Outcomes (5)

  • Symmetry Ratio of Stride Length

    Baseline through week 3

  • Gait Velocity

    Baseline through week 3

  • Symmetry of Percentage of Time in Swing Phase of Gait

    Baseline through week 3

  • Time Spent in Double Support Phase of Gait

    Baseline through week 3

  • Berg Balance Scale

    Baseline through week 3

Study Arms (1)

Tethered Pelvic Assist Device (TPAD) Treatment

EXPERIMENTAL

All participants will receive 5 consecutive days of training with the TPAD (tethered pelvic assist device) with testing completed before training, on completion of training and at a 1-week follow up.

Device: TPAD (Tethered Pelvic Assist Device)

Interventions

Each day of intervention will include a 1-hour treadmill based intervention to promote increased loading onto the affected limb. Visual feedback will be provided and faded over the course of the 5-day training. Immediately on completion of the treadmill intervention, participants will receive an additional 5-10 minutes of overground intervention reinforcing weight shifting onto the affected limb.

Tethered Pelvic Assist Device (TPAD) Treatment

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic (\>6 months) post stroke
  • Single stroke event
  • Montreal Cognitive Assessment (MoCA) score of \>22
  • Independently ambulating in the home
  • Use of a unilateral assistive device (e.g. cane)
  • Marked asymmetry in stance phase (defined by a symmetry ratio \< 0.90)

You may not qualify if:

  • History of multiple strokes
  • History of other neurological disease
  • Uncontrolled medical issues
  • Muscle contractures of the lower limb limiting range of motion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

Related Publications (1)

  • Bishop L, Omofuma I, Stein J, Agrawal S, Quinn L. Treadmill-Based Locomotor Training With Robotic Pelvic Assist and Visual Feedback: A Feasibility Study. J Neurol Phys Ther. 2020 Jul;44(3):205-213. doi: 10.1097/NPT.0000000000000317.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Sunil Agrawal, PhD
Organization
Columbia University Irving Medical Center

Study Officials

  • Sunil Agrawal, PhD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Mechanical Engineering and of Rehabilitation and Regenerative Medicine

Study Record Dates

First Submitted

June 24, 2017

First Posted

June 29, 2017

Study Start

April 1, 2017

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

June 9, 2020

Results First Posted

October 28, 2019

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations